Recurrent miscariage. Pregnancy care of habitual aborter
Conditions
Interventions
Intervention 1: Medical Therapy with Aspirin and Placebo with a daily dose of 100 mg. Intervention 2: Medical Therapy with Vitamin E and Placebo at a Dose of 400 mg daily. Intervention 3: Drug Therapy
Treatment - Drugs
Medical Therapy with Aspirin and Placebo with a daily dose of 100 mg.
Medical Therapy with Vitamin E and Placebo at a Dose of 400 mg daily
Drug Therapy with Aspirin and Vitamin E daily
Sponsors
Vice chancellor for research, Kashan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: recurrent miscarriage patients with impaired uterine perfusion Exclusion criteria: the use of hormonal contraceptives in the last 3 months; use of intrauterine contraceptive method; pregnant women; use of aspirin and vitamin E in the recent week
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uterine Artery Blood Flow Velocity. Timepoint: Baseline and Three Months After Begining of Treatment. Method of measurement: Ultrasonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| --. Timepoint: --. Method of measurement: --. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBehnaz Mohammad Ebrahimi
Kashan University of Medical Sciences
Outcome results
None listed